Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy

被引:62
作者
Carcopino, X.
Henry, M.
Benmoura, D.
Fallabregues, A. S.
Richet, H.
Boubli, L.
Tamalet, C.
机构
[1] Hop La Timone, Virol Lab, F-13385 Marseille 05, France
[2] Hop Nord Marseille, Serv Gynecol Obstet, Marseille 20, France
[3] Univ Mediterranee, Fac Med, CNRS, UMR 6020,IFR 48, Marseille 05, France
关键词
human papillomavirus; real-time PCR; viral load; cervical cancer;
D O I
10.1002/jmv.20673
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It has been recognized that human papillomavirus infection is the major causal factor for highgrade cervical lesions. The aim of the study was to evaluate the relationship between HPV 16 and 18 viral loads and cervical status in different age strata. A duplex real time PCR method was devised to determine HPV 16 and 18 viral load per million of human cells using an in house plasmidic construct as a standard of quantification. The 151 cervical scrapes were collected before colposcopic examination from either abnormal cervico-vaginal smear (group 1, 97 patients) or from post treatment clinical follow-up (group 2, 54 patients). In women aged 30-40, the HPV16 viral loads were significantly higher in high-grade squamous intraepithelial lesion than in low-grade squamous intraepithelial lesion in both groups and HPV18 in group 1. In women aged 20-30 of group 1, high HPV viral load was associated in few cases with high-grade squamous intraepithelial lesion or low-grade squamous intraepithelial lesion, and surprisingly in some patients with normal cervix. HPV 16 and 18 viral loads are related to the severity of cervical lesion, and may be useful in the clinical management of cervical lesions. A specific follow-up may be useful for those with high viral load despite normal cervix.
引用
收藏
页码:1131 / 1140
页数:10
相关论文
共 42 条
[1]  
ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415
[2]   Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security [J].
Beby-Defaux, A ;
Bourgoin, A ;
Ragot, S ;
Battandier, D ;
Lemasson, JM ;
Renaud, O ;
Bouguermouh, S ;
Agius, G .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (02) :262-268
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[5]   Management of women who test positive for high-risk types of human papillomavirus: the HART study [J].
Cuzick, J ;
Szarewski, A ;
Cubie, H ;
Hulman, G ;
Kitchener, H ;
Luesley, D ;
McGoogan, E ;
Menon, U ;
Terry, G ;
Edwards, R ;
Brooks, C ;
Desai, M ;
Gie, C ;
Ho, L ;
Jacobs, I ;
Pickles, C ;
Sasieni, P .
LANCET, 2003, 362 (9399) :1871-1876
[6]   HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING [J].
CUZICK, J ;
SZAREWSKI, A ;
TERRY, G ;
HO, L ;
HANBY, A ;
MADDOX, P ;
ANDERSON, M ;
KOCJAN, G ;
STEELE, ST ;
GUILLEBAUD, J .
LANCET, 1995, 345 (8964) :1533-1536
[7]   Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study [J].
Dalstein, W ;
Riethmuller, D ;
Prétet, JL ;
Carval, KL ;
Sautière, JL ;
Carbillet, JP ;
Kantelip, B ;
Schaal, JP ;
Mougin, C .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :396-403
[8]   Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer [J].
Dillner, J ;
Lehtinen, M ;
Bjorge, T ;
Luostarinen, T ;
Youngman, L ;
Jellum, E ;
Koskela, P ;
Gislefoss, RE ;
Hallmans, G ;
Paavonen, J ;
Sapp, M ;
Schiller, JT ;
Hakulinen, T ;
Thoresen, S ;
Hakama, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1293-1299
[9]  
Ferlay J, 2004, GLOBOCAN 2002 CANC I
[10]   HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization [J].
Forslund, O ;
Lindqvist, P ;
Haadem, K ;
Czeglédy, J ;
Hansson, BG .
JOURNAL OF VIROLOGICAL METHODS, 1997, 69 (1-2) :209-222